Keyphrases
Glucagon-like
100%
Antiretroviral Therapy
100%
HIV Patients
100%
Intolerant
100%
Oral Glucose
100%
Glucose-dependent Insulinotropic Polypeptide
71%
Incremental Area under the Curve
71%
Male Patients
57%
Impaired Glucose Tolerance
57%
Insulin Secretion Rate
42%
Highly Active Antiretroviral Therapy (HAART)
28%
Normal Glucose Tolerance
28%
Plasma Concentration
14%
Plasma Glucose
14%
C-peptide
14%
Peptide Concentration
14%
Non-diabetic
14%
Deconvolution
14%
Glucose Tolerance
14%
Insulin Secretion
14%
Glucose-tolerant
14%
Incretin Hormones
14%
Compensatory Mechanisms
14%
75-g Oral Glucose Tolerance Test
14%
Pooled Study
14%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Antiretroviral Therapy
100%
Glucagon Like Peptide 1
100%
Gastric Inhibitory Polypeptide
71%
Impaired Glucose Tolerance
57%
Insulin Release
57%
Glucose Tolerance
42%
Highly Active Antiretroviral Therapy
28%
Incretin
14%
C-Peptide
14%
Glucose Test
14%
Agricultural and Biological Sciences
Human Immunodeficiency Virus
100%
Glucagon-Like Peptide-1
100%
Gastric Inhibitory Polypeptide
71%
Insulin Secretion
57%
Impaired Glucose Tolerance
57%
Glucose Tolerance
42%
Incretin
14%
Glucose Tolerance Test
14%
Glucose Test
14%
C-Peptide
14%
Biochemistry, Genetics and Molecular Biology
Human Immunodeficiency Virus
100%
Glucagon-Like Peptide-1
100%
Gastric Inhibitory Polypeptide
71%
Impaired Glucose Tolerance
57%
Insulin Release
57%
Blood Level
14%
Glucose Blood Level
14%
C-Peptide
14%
Glucose Test
14%
Glucose Tolerance Test
14%
Incretin
14%